Biological Material Prepared, Recovered, Or Treated (e.g., Urine, Etc.) Patents (Class 204/540)
  • Publication number: 20150014169
    Abstract: The disclosure relates to efficient methods of controlling biological conversions while simultaneously removing and converting some of the generated products. More specifically, and, for example, the disclosure discloses electrochemical processes to remove and capture potentially toxic ammonium during anaerobic digestions and to remove and capture carboxylic acids during bioethanol production. The disclosure can, thus, be used to enhance bioproduction processes via controlling pH and/or reduction/oxidation, in combination with in situ product recovery.
    Type: Application
    Filed: January 30, 2013
    Publication date: January 15, 2015
    Inventors: Korneel Rabaey, Christian Stevens
  • Publication number: 20140318969
    Abstract: Biomass (e.g., plant biomass, animal biomass, and municipal waste biomass) is processed to produce useful intermediates and products, such as energy, fuels, foods or materials. Systems, methods and equipment are described for upgrading process streams using electrodialysis or electrodialysis reversal.
    Type: Application
    Filed: June 9, 2014
    Publication date: October 30, 2014
    Inventors: Marshall MEDOFF, Thomas Craig MASTERMAN, Maia Stapleton MUKHERJEE, Christopher COOPER
  • Publication number: 20140238859
    Abstract: Provided herein is technology relating to sequencing nucleic acids and particularly, but not exclusively, to devices, methods, and systems for sequencing-by-synthesis using changes in pH to monitor base addition. In some embodiments the electrochemical hydrogen ion sensor is a microfabricated mixed metal oxide electrode and in some embodiments the electrochemical hydrogen ion sensor is a membrane electrode. Moreover, in some embodiments the device further comprises a reference electrode. Performing the sequencing reaction involves moving solutions and other fluids (e.g., samples, nucleotide solutions, wash solutions) into and out of the reaction vessel. Thus, in some embodiments, the device further comprises a tube or other transport mechanism or pathway attached to the reaction vessel.
    Type: Application
    Filed: August 3, 2012
    Publication date: August 28, 2014
    Applicant: IBIS BIOSCIENCES, INC.
    Inventors: Jeffrey Huff, Graham Davis, Mark Hayden, David J. Ecker, Dan Wang, Gordon Bruce Collier
  • Patent number: 8404091
    Abstract: Dialysis treatment devices and methods for removing urea from dialysis waste streams are provided. In a general embodiment, the present disclosure provides a dialysis treatment device including a first cell having a first electrodialysis unit, a second cell having at least one of a urease compartment and a sorbent compartment and in fluid communication with the first cell, and a third cell having a second electrodialysis unit and in fluid communication with the second cell.
    Type: Grant
    Filed: August 27, 2009
    Date of Patent: March 26, 2013
    Assignees: Baxter International Inc., Baxter Healthcare S.A.
    Inventors: Yuanpang Samuel Ding, Ying-Cheng Lo
  • Patent number: 8317991
    Abstract: Device and Process for isolating, purifying, concentrating and/or enriching at least one organic compound by electrokinetic migration through liquid membranes by use of an electronic potential and chambers with a preset pH value is described in the present application. The liquid membranes contain an organic solvent capable of transporting an ionized form of said at least one organic compound.
    Type: Grant
    Filed: June 30, 2006
    Date of Patent: November 27, 2012
    Inventors: Stig Pedersen-Bjergaard, Knut Einar Rasmussen
  • Publication number: 20120160687
    Abstract: The invention relates to a method for detecting a double-stranded region in a nucleic acid by (1) providing two separate, adjacent pools of a medium and a interface between the two pools, the interface having a channel so dimensioned as to allow sequential monomer-by-monomer passage of a single-stranded nucleic acid, but not of a double-stranded nucleic acid, from one pool to the other pool; (2) placing a nucleic acid polymer in one of the two pools; and (3) taking measurements as each of the nucleotide monomers of the single-stranded nucleic acid polymer passes through the channel so as to differentiate between nucleotide monomers that are hybridized to another nucleotide monomer before entering the channel and nucleotide monomers that are not hybridized to another nucleotide monomer before entering the channel.
    Type: Application
    Filed: July 20, 2011
    Publication date: June 28, 2012
    Applicant: President and Fellows of Harvard College
    Inventors: Mark Akeson, Daniel Branton, George Church, David W. Deamer
  • Publication number: 20120090998
    Abstract: A process for separating a cell type from a mixture of cell types by electrophoresis comprising providing a sample containing a mixture of cell types to a sample chamber of a membrane-based electrophoresis apparatus adapted to separate cells and applying an electric potential causing at least one cell type in the sample to be separated from other cells in the sample.
    Type: Application
    Filed: December 9, 2011
    Publication date: April 19, 2012
    Applicant: NUSEP HOLDINGS LTD.
    Inventors: Dennis Rylatt, Sharon Leong
  • Patent number: 8142633
    Abstract: A treatment system and method for continuous deionization of a biologically derived feed stream includes a plurality of electrodialysis units (3, 9, 10, 11, 12, 13) arranged in stages along a treatment line, and stages are controlled such that the feed stream attains a certain quality before entering the next stage. The feed and concentrate streams move in generally opposite sense along the line, matching fluid characteristics of dilute and concentrate cells. The treatment line has two or more stages. Systems may have phased staging operations, and cell constructions may adapt the electrodialysis units for enhanced processing of difficult process fluids. A controller sets operating potentials in different electrical stages, and simple control parameters optimize ion removal and current efficiency without polarization of the fluid. The invention also includes phased staging of reversal operation, and cell constructions or fillings that adapt the treatment cells for enhanced processing.
    Type: Grant
    Filed: October 27, 2004
    Date of Patent: March 27, 2012
    Assignee: GE Ionics, Inc.
    Inventors: Bruce Batchelder, Li Zhang, William W. Carson
  • Publication number: 20110311965
    Abstract: The invention relates to enhancing translocation of a charged analyte through a transmembrane protein pore. Translocation is enhanced by increasing the net opposing charge of the barrel or channel and/or entrance of the pore. The invention also relates to pores enhanced in accordance with the invention.
    Type: Application
    Filed: November 13, 2009
    Publication date: December 22, 2011
    Applicant: ISIS INNOVATION LIMITED
    Inventors: Giovanni Maglia, John Hagan Pryce Bayley
  • Patent number: 8075780
    Abstract: The present invention is an ultrafiltration (UF) membrane having a nominal molecular weight cut off (NMWCO) of from about 0.5 KD to about 10 KD wherein the membrane surfaces have a charge that is either positive or negative. The present invention is also a method of using the charged UF membrane to purify and concentrate synthetic biological molecules by using the charged surface either to repel the synthetic biomolecules retaining them in the retentate or to attract the synthetic biomolecules preferentially for filtration through the membrane.
    Type: Grant
    Filed: November 4, 2004
    Date of Patent: December 13, 2011
    Assignee: Millipore Corporation
    Inventor: Richard James Pearce
  • Patent number: 8057680
    Abstract: The scope of the invention is to apply an electric current or to use a kind of iontophoresis system with the hemodialysis cartridge and system (the proposed method is also applicable to peritoneal dialysis or other similar methods) to remove unwanted molecules from blood, plasma or serum or other body fluids and to increase the effectiveness of the process. This cartridge can be used for patients with uremia and cartridge fixed to the conventional hemodialysis machine and additionally the electric current applied to the electrodes placed in to the cartridge or electrode connectors placed to the conventional cartridge. When the system activated, the molecules in the blood or other body fluid migrates to the hemodialysis solution. Charged ions or uncharged molecules move together with electroosmotic flow. The sterilized electrodes preferably made by Ag/AgCl to prevent pH changing effect. Other apparatus can also be used for providing an electropotential gradient.
    Type: Grant
    Filed: November 19, 2002
    Date of Patent: November 15, 2011
    Assignee: Dizayn Teknik Plastik Boru Ve Elemanlari Sanayi Ve Ticaret A.S.
    Inventors: Tuncer Degim, Rusen Dundaroz, Metin Denli, Sibel Ilbasmis, Tanju Ozcelikay, Zelihagul Degim
  • Publication number: 20110120871
    Abstract: To form a layer separating two volumes of aqueous solution, there is used an apparatus comprising elements defining a chamber, the elements including a body of non-conductive material having formed therein at least one recess opening into the chamber, the recess containing an electrode. A pre-treatment coating of a hydrophobic fluid is applied to the body across the recess. Aqueous solution, having amphiphilic molecules added thereto, is flowed across the body to cover the recess so that aqueous solution is introduced into the recess from the chamber and a layer of the amphiphilic molecules forms across the recess separating a volume of aqueous solution introduced into the recess from the remaining volume of aqueous solution.
    Type: Application
    Filed: December 15, 2008
    Publication date: May 26, 2011
    Inventors: Stuart William Reid, Terence Alan Reid, James Anthony Clarke, Steven Paul White, Gurdial Singh Sanghera
  • Publication number: 20110111029
    Abstract: A composition for transdermal delivery, particularly iontophoretic transdermal delivery, having at least one cationic active agent or a salt thereof. The composition comprises at least one cationic active agent or a salt thereof, at least one polyamine and/or polyamine salt, water or an aqueous solvent mixture, and optionally one or more additives. Use of the composition as a component of a transdermal patch or of an iontophoretic transdermal patch is also provided, as well as the use of the composition in a method for transdermally or iontophoretically administering cationic active agents. A method for determining the in vitro skin permeation properties of an active agent-containing iontophoretic composition is also provided.
    Type: Application
    Filed: June 16, 2009
    Publication date: May 12, 2011
    Applicant: LTS Lohmann Therapie-Systeme AG
    Inventors: Christoph Schmitz, Mohammad Sameti, Andreas Koch, Michael Horstmann
  • Publication number: 20100224492
    Abstract: Systems and methods for hemodialysis or peritoneal dialysis having integrated electrodeionization capabilities are provided. In an embodiment, the dialysis system includes a carbon source, a urease source and an electrodeionization unit. The carbon source and urease source can be in the form of removable cartridges.
    Type: Application
    Filed: March 5, 2010
    Publication date: September 9, 2010
    Applicants: BAXTER INTERNATIONAL INC., BAXTER HEALTHCARE S.A.
    Inventors: Yuanpang Samuel Ding, Ying-Cheng Lo, Joshua James Miller, Justin Rohde, Sujatha Karoor
  • Patent number: 7722751
    Abstract: An apparatus for regulating salt concentration, a lab-on-a-chip including the same and a method of regulating salt concentration using the apparatus are provided. The apparatus includes: a reaction chamber that is defined by a cation exchange membrane and an anion exchange membrane and is selected from the group consisting of a biomolecule extraction chamber, an amplification chamber, a hybridization chamber, and a detection chamber; a first electrode chamber that is defined by the anion exchange membrane and a first electrode and includes an ion exchange medium; and a second electrode chamber that is defined by the cation exchange membrane and a second electrode and includes an ion exchange medium. Even without injecting solutions with different salt concentrations into the reaction chamber by operating pumps and valves for each operation stage, the salt concentration can be reversibly regulated in situ by adjusting the polarity, intensity and application time of a voltage.
    Type: Grant
    Filed: May 25, 2006
    Date of Patent: May 25, 2010
    Assignee: Samung Electronics Co., Ltd.
    Inventors: Jung-im Han, Young-sun Lee, Joon-ho Kim
  • Publication number: 20100072066
    Abstract: Device and Process for isolating, purifying, concentrating and/or enriching at least one organic compound by electrokinetic migration through liquid membranes by use of an electronic potential and chambers with a preset pH value is described in the present application. The liquid membranes contain an organic solvent capable of transporting an ionized form of said at least one organic compound.
    Type: Application
    Filed: June 30, 2006
    Publication date: March 25, 2010
    Inventors: Stig Pedersen-Bjergaard, Knut Einar Rasmussen
  • Patent number: 7544278
    Abstract: The invention includes novel anion exchange membranes formed by in situ polymerization of at least one monomer, polymer or copolymer on a woven support membrane and their methods of formation. The woven support membrane is preferably a woven PVC membrane. The invention also includes novel cation exchange membranes with or without woven support membranes and their methods of formation. The invention encompasses a process for using the membranes in electrodialysis of ionic solutions and in particular industrial effluents or brackish water or seawater. The electrodialysis process need not include a step to remove excess ions prior to electrodialysis and produces less waste by-product and/or by-products which can be recycled.
    Type: Grant
    Filed: April 19, 2004
    Date of Patent: June 9, 2009
    Assignee: Seventy-Seventh Meridian Corporation, LLC
    Inventors: Tejraj Aminabhavi, Padmakar V. Kulkarni, Mahadevappa Y. Kariduraganavar
  • Publication number: 20090101507
    Abstract: A process for separating a sperm type from a sperm population by electrophoresis comprising subjecting the sperm population to an electric potential such that a sperm type is separated from a sperm population through an ion-permeable barrier.
    Type: Application
    Filed: October 7, 2004
    Publication date: April 23, 2009
    Inventors: Robert J. Aitken, Christopher J. Ainsworth
  • Publication number: 20080067070
    Abstract: A process for separating a cell type from a mixture of cell types by electrophoresis comprising providing a sample containing a mixture of cell types to a sample chamber of membrane-based electrophoresis apparatus adapted to separate cells and applying an electric potential causing at least one cell type in the sample to be separated from other cells in the sample.
    Type: Application
    Filed: May 14, 2004
    Publication date: March 20, 2008
    Inventors: Dennis Rylatt, Sharon Leong
  • Patent number: 7217349
    Abstract: The invention pertains to a method of separating multivalent ions and lactate ions from a fermentation broth comprising a multivalent ion lactate salt by using an electrodialysis or electrolysis apparatus, comprising the steps of introducing the broth wherein the multivalent ion concentration is at least 0.1 mole/l, the lactate ion concentration is less than 300 g/l, and less than 10 mole % of the lactate ion are other negatively charged ions, into a first compartment of the electrodialysis or electrolysis apparatus, which compartment is limited by an anion-selective or non-selective membrane and a cathode, and wherein the multivalent ion is converted to obtain a residual stream comprising the hydroxide of the multivalent ion, and the lactate ion is transported through the anion-selective or non-selective membrane into a second compartment limited by the anion-selective or non-selective membrane and an anode, after which the lactate ion is neutralized to lactic acid.
    Type: Grant
    Filed: October 28, 2003
    Date of Patent: May 15, 2007
    Assignee: Purac Biochem B.V.
    Inventors: Peter Baets, Willem Jacob Groot
  • Publication number: 20030226752
    Abstract: A method for altering the initial composition of an ampholytic component containing sample by isoelectric trapping provides for selecting a first isoelectric buffer having a pI value different from the pI value of a first ampholytic sample component in the sample, contacting the isoelectric buffer with the first ampholytic sample component, and obtaining the first ampholytic sample component in a non-isoelectric state on one side of an isoelectric separation barrier at the end of an isoelectric trapping process.
    Type: Application
    Filed: June 5, 2002
    Publication date: December 11, 2003
    Applicant: Gradipore Limited
    Inventor: Gyula Vigh
  • Publication number: 20030047455
    Abstract: The claims describe methods and apparatus for obtaining a target component from a milk source using a membrane-based electrophoresis separation system. They may also be used in conjunction with or as a substitute for one or more steps in a conventional purification scheme for obtaining target component from a milk source.
    Type: Application
    Filed: August 6, 2002
    Publication date: March 13, 2003
    Applicant: Gradipore Limited
    Inventors: Lucy Jane Ryan, Stewart Andrew Smith, Elizabeth Jean Seabrook, Philip John Roeth
  • Patent number: 6428666
    Abstract: A method for separating and concentrating charged species from uncharged or neutral species regardless of size differential. The method uses reversible electric field induced retention of charged species, that can include molecules and molecular aggregates such as dimers, polymers, multimers, colloids, micelles, and liposomes, in volumes and on surfaces of porous materials. The retained charged species are subsequently quantitatively removed from the porous material by a pressure driven flow that passes through the retention volume and is independent of direction thus, a multi-directional flow field is not required. Uncharged species pass through the system unimpeded thus effecting a complete separation of charged and uncharged species and making possible concentration factors greater than 1000-fold.
    Type: Grant
    Filed: February 22, 1999
    Date of Patent: August 6, 2002
    Assignee: Sandia National Laboratories
    Inventors: Anup K. Singh, David W. Neyer, Joseph S. Schoeniger, Michael G. Garguilo
  • Patent number: 6110342
    Abstract: The invention uses a stack of three compartment electrodialysis cells in a process for the production amino acid hydrochloride and an alkali. The electrodialysis cell contains bipolar, cation and anion membranes which are arranged to form acid, base and salt compartments. The process begins with supplying a salt solution to the salt compartment, water to the base compartment, and a liquid comprising an amino acid to the acid compartment. Preferably, the feed salt is sodium chloride or potassium chloride or lithium chloride. A direct current driving force is applied across the cell to convert the salt solution to an alkali in the base compartments and an amino acid hydrochloride in the acid compartment. The acid and alkali solutions and a depleted salt solution are withdrawn from their respective compartments. A chelating agent may be added to the salt solution before it is fed into the electrodialysis cell.
    Type: Grant
    Filed: December 30, 1998
    Date of Patent: August 29, 2000
    Assignee: Archer Daniels Midland Company
    Inventor: K. N. Mani
  • Patent number: 5814197
    Abstract: Improved electrodialysis (ED) stacks are disclosed having one or more components selected from the group:a) cation exchange membranes having ion exchange groups predominantly sulfonic acid groups and a minor amount of weakly acidic and/or weakly basic groups or membranes which are selective to monovalent cations and simultaneously therewith, cation exchange granules selective to monovalent cations as packing in the dilute compartments;b) anion exchange membranes having as ion exchange groups only quaternary ammonium and/or quaternary phosphonium groups and substantially no primary, secondary and/or tertiary amine and/or phosphine groups or membranes which are selective to monovalent anions simultaneously therewith, anion exchange granules selective to monovalent anions as packing in the dilute compartments;c) as packing in the dilute compartment, anion exchange granules which are selective to monovalent anions, or cation exchange granules which are selective to monovalent cations, or cation exchange granules
    Type: Grant
    Filed: December 16, 1996
    Date of Patent: September 29, 1998
    Assignee: Ionics, Incorporated
    Inventors: Bruce T. Batchelder, Irving D. Elyanow, Arthur L. Goldstein, Russell J. MacDonald, Wayne A. McRae, Keith J. Sims, Li Zhang
  • Patent number: 5746920
    Abstract: A process and apparatus for purifying lactose-containing wastewater. The process comprises first treating the wastewater with base. The treated wastewater is then introduced into a fermenter where the lactose present in the wastewater is fermented to form a fermentation broth and lactic acid. The broth is advantageously subjected to purification and the purified broth is subjected to bipolar electrodialysis to yield concentrated lactic acid and base solutions from the purified broth. A device is provided for carrying out the process.
    Type: Grant
    Filed: February 8, 1996
    Date of Patent: May 5, 1998
    Assignee: Fraunhofer-Gesellschaft zur Foerder der Angewandten Forschung e.V.
    Inventors: Peter Boergardts, Wolfgang Krischke, Walter Troesch
  • Patent number: 5725749
    Abstract: The invention relates to a process for the separation of lactulose from a mixture of lactulose and lactose in the presence of a weak acid capable of reversibly forming a complex with lactulose, by using an electrodialysis equipment including an anode and a cathode compartment separated by a plurality of parallel compartments comprising alternating diluate and concentrate compartments, wherein adjacent compartments are separated from each other by permselective membranes; which process is characterized by:(a) continuously passing an alkaline aqueous solution of lactulose, lactose and said complex forming weak acid through the diluate compartments, each diluate compartment being bound by a bipolar membrane at its lateral side facing the cathode and at its opposite lateral side by an anion exchange membrane, separating said compartment from its adjacent concentrate compartment;(b) continuously passing a carrier fluid through the concentrate compartments, each concentrate compartment being bound at its lateral si
    Type: Grant
    Filed: October 29, 1996
    Date of Patent: March 10, 1998
    Assignee: Duphar International Research B.V.
    Inventor: Hendrik Pluim